# Ginkgo Bioworks Holdings Inc. (DNA) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Healthcare / Biotechnology. Price $10.76, market value $725 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Ginkgo Bioworks Holdings Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 5.9×**. Each dollar of revenue is priced at 5.9×.
- **Price / book: 1.6×**. The shares trade at 1.6× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -24.1%** (5-yr avg -27.5%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Operating margin: -244.9%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -183.8%**. The company reported a net loss over the last twelve months.
- **Return on equity: -61.5%**. Return on equity is negative because earnings are negative.
- **Return on assets: -26.0%**. Each dollar of assets produces -26.0% of profit.

## Growth
- **Revenue growth (1 yr): -25.1%** (3-yr -29.1%/yr, 5-yr 17.3%/yr). Revenue fell 25.1% over the last year, against 17.3% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 46.5%**. Earnings per share rose 46.5%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Current ratio: 4.92** (quick 4.92). Current assets cover the next year's liabilities 4.92 times.
- **Altman Z-score: 0.97**. A Z-score of 0.97 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Ginkgo Bioworks Holdings Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -24.2%** (YTD 18.5%, 3-mo 10.2%). The shares are down 24.2% over twelve months including dividends.
- **From 52-week high: -40.9%** (100.4% above the low). Trading 41% below its 52-week high, deep in a drawdown.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 46**. An RSI of 46 is neutral.
- **Beta (1 yr): 3.19** (volatility 103%). Beta of 3.19 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=DNA · Page: https://foliofundamentals.com/stocks/dna

Not investment advice.